US Drug Importation & Drug Shortages
The Trump administration’s proposal to allow imports of prescription drugs from Canada has caused alarm among Canadians. Are serious drug shortages a real threat?
Join us on May 5th in Nashville, TN, at the CAPDM Annual Conference as an expert panel led by moderator David Simmonds, Senior VP, McKesson Canada, weighs in on this imposing US legislation.
MODERATOR: David Simmonds, SR VP, Communication & Public Affairs, McKesson Canada
David leads communications, external affairs, media relations, government relations, and strategic partnerships for McKesson’s business units in Canada.
Manufacturer: Michel Robidoux, President & GM, Sandoz
With over 30 years of experience in the pharmaceutical & medical equipment industries, Mr Robidoux leads one of the largest pharmaceutical companies in Canada.
Patient: Dawn Richards, PhD Patient Advocate Five02 Labs
Dawn’s firm, Five02 Labs Inc., intertwines her formal training as an analytical chemist with her passion for the patient perspective to inform research and healthcare.
Pharmacist: Beverly Herczegh R.Ph., Director, Pangaea
Bev Herczegh drives innovation within healthcare organizations by aligning corporate strategy with a unique strategic interpretation of the Pharmacy profession using the latest market insights.
Physician: Dr. Paul Keith, Associate Professor of Medicine, McMaster University
Dr. Keith is an Associate Professor of Medicine, in the Division of Allergy and Clinical Immunology at McMaster. He is extensively involved in medical education and has an active hospital based clinical practice.
Safety Advocate: Shabbir Safdar, Executive Director, Partnership for Safe Medicines
Shabbir is passionate about patient safety. He leads the Partnership for Safe Medicines which focuses on researching the danger of counterfeit drugs in America.